Followers | 29 |
Posts | 2446 |
Boards Moderated | 0 |
Alias Born | 11/22/2010 |
Tuesday, June 20, 2017 9:46:34 PM
next news will be cash related as they are walking towards a zero cash situation. August/Sept = Bankruptcy.. but as long as Fast Field trials product same or better results than last year, BK is not on the cards. Getting Cash into the Business for day to day operations is essential though
disclosure
Sold 3/4 of my position on that run up to $9.00. Am now adding on dips into the $4.00s now. small blocks as a time. did not buy any in the $5s and don't intend to for moment. could be couple months before we hear more from Co and this will lead to fear and share price weakness. Just My Opinion. could be completely wrong
Recent YTEN News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/07/2024 08:01:17 PM
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests • GlobeNewswire Inc. • 02/29/2024 01:31:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:37:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 03:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:29:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:26:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:25:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 05:45:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 04:34:18 PM
- Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock • GlobeNewswire Inc. • 02/14/2024 02:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:19:22 PM
- Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program • GlobeNewswire Inc. • 02/07/2024 10:40:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:47:54 AM
- Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil • GlobeNewswire Inc. • 01/08/2024 01:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:35:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:29:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:11:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:27:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:59:53 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States • GlobeNewswire Inc. • 11/15/2023 01:32:19 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM